Roger Wiederkehr Appointed Wyle CEO, George Melton to Stay as Chair

Wyle logoRoger Wiederkehr, chief operating officer at Wyle Laboratories for two years, will succeed George Melton as president and CEO of the engineering and scientific services contractor at the end of this year.

Wyle said Tuesday Melton, who has held the president and CEO titles for nine years, will continue to serve as chairman of the board of directors at the El Segundo, Calif.-based company.

“This decision was made as part of our planned succession process, which has been implemented over the last two years, ” Melton said.

Wiederkehr joined Wyle’s executive team in 2005 and has held roles with responsibility over mergers and acquisitions,  planning activities, contracts, procurement, legal, security,  environmental, health and safety functions.

He led the day-to-day operations of the company’s test, engineering and research division between 2008 and 2011 and has served as a member of URS Corp.’s corporate strategy group .

Melton served as president of URS’ EG&G division,  CEO of EG&G and president of several aerospace component and sub-system manufacturers that were ultimately acquired by BAE Systems.

You may also be interested in...

Gil Dussek CEO Gunnison Consulting Group

Gunnison Buys Federal IT Service Management Firm G2SF; Gil Dussek Quoted

Gunnison Consulting Group has acquired Global Solutions & Services Frameworks for an undisclosed sum to expand its information technology service management, mobile computing and cybersecurity capabilities in the federal government services market. “This deal aligns with our modernization strategy and we remain focused on improving critical government programs, while driving long-term innovation to meet evolving customer demands," said Gunnison CEO Gil Dussek.


Cybersecurity Firm Telos Launches IPO

Telos (Nasdaq: TLS) targeted to raise approximately $254M from the Ashburn, Virginia-based cybersecurity company's initial public offering Thursday, offering 15M shares of common stock with pricing at $17 each.